Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ba-34,276
2. Ba34,276
3. Deprilept
4. Dibencycladine
5. Hydrochloride, Maprotiline
6. Ludiomil
7. Maprolu
8. Maprotilin
9. Maprotilin Holsten
10. Maprotilin Neuraxpharm
11. Maprotilin Ratiopharm
12. Maprotilin Teva
13. Maprotilin Von Ct
14. Maprotilin-neuraxpharm
15. Maprotilin-ratiopharm
16. Maprotilin-teva
17. Maprotiline
18. Maprotiline Mesylate
19. Mesylate, Maprotiline
20. Mirpan
21. N-methyl-9,10-ethanoanthracene-9(10h)-propylamine
22. Novo Maprotiline
23. Novo-maprotiline
24. Psymion
1. 10347-81-6
2. Maprotiline Hcl
3. Ludiomil
4. Psymion
5. Deprilept
6. 9-(gamma-methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene Hydrochloride
7. Maprotilline Hcl
8. Maprotiline (hydrochloride)
9. Maprotiline, Hcl
10. Maprotiline Hydrochlorine
11. Nsc-757085
12. 9,10-ethanoanthracene-9(10h)-propanamine, N-methyl-, Hydrochloride
13. 7c8j54pvfi
14. Mls000069552
15. Mls000557000
16. N-methyl-9,10-ethanoanthracene-9(10h)-propanamine Hydrochloride
17. N-methyl-9,10-ethanoanthracene-9(10h)-propylamine Hydrochloride
18. 3-(9,10-ethanoanthracen-9(10h)-yl)-n-methylpropan-1-amine Hydrochloride
19. Ba-34,276
20. Smr000058834
21. Smr000148117
22. 1-(3-methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene Hydrochloride
23. Ba-34276
24. Ciba 34276 Ba
25. 1-(3-methylaminopropyl)dibenzo[b,e]bicyclo[2.2.2]octadienehydrochloride;1-(3-methylaminopropyl)dibenzo[b,e]bicyclo[2.2.2]octadienehydrochloride
26. Sr-01000076016
27. Einecs 233-758-8
28. Cas-10347-81-6
29. Unii-7c8j54pvfi
30. Ba 34276
31. Maprotilinehcl
32. Maprotiline Hydrochloride [jan]
33. 1-(3-methylaminopropyl)dibenzo[b,e]bicyclo[2.2.2]octadiene Hydrochloride
34. Ludiomil (tn)
35. Prestwick_749
36. Maprotiline Hydrochloride [usp:jan]
37. Mfcd00079464
38. Cpd000148117
39. Opera_id_513
40. Opera_id_1466
41. Dsstox_cid_24507
42. Dsstox_rid_80277
43. Dsstox_gsid_44507
44. Mls000758284
45. Mls001148189
46. Mls001423998
47. Schembl121014
48. Spectrum1500373
49. Regid_for_cid_71478
50. Chebi:6691
51. Chembl1200427
52. Chembl1237135
53. Dtxsid2044507
54. Maprotiline Hcl;ludiomil;psymion
55. Ba-34276 Hydrochloride
56. Hms1569e13
57. Hms1920j13
58. Kuc112481c
59. Pharmakon1600-01500373
60. Maprotiline, Ludiomil Hydrochloride
61. Bcp23366
62. Hy-b0444
63. Str09724
64. Tox21_300992
65. Tox21_500812
66. 9,10-ethanoanthracene-9(10h)-propylamine, N-methyl-, Hydrochloride
67. Ccg-38957
68. Nsc757085
69. S2517
70. Maprotiline Hydrochloride [mi]
71. Akos015961872
72. Akos015994755
73. Maprotiline Hydrochloride (jp17/usp)
74. Ac-8249
75. Bcp9000894
76. Ccg-220346
77. Ks-5095
78. Lp00812
79. Nc00056
80. Nsc 757085
81. Maprotiline Hydrochloride [mart.]
82. Maprotiline Hydrochloride [vandf]
83. Ncgc00094145-01
84. Ncgc00094145-02
85. Ncgc00094145-03
86. Ncgc00094145-04
87. Ncgc00254894-01
88. Ncgc00261497-01
89. Bm164655
90. Ksc-315-031-
91. Maprotiline Hydrochloride [usp-rs]
92. Maprotiline Hydrochloride [who-dd]
93. Bcp0726000234
94. Eu-0100812
95. Ft-0659758
96. M2527
97. Sw196892-3
98. D00818
99. M 9651
100. Maprotiline Hydrochloride [ep Monograph]
101. Maprotiline Hydrochloride [orange Book]
102. T71539
103. Maprotiline Hydrochloride [usp Monograph]
104. Maprotiline Hydrochloride, >99% (hplc), Powder
105. 347m816
106. A907819
107. Sr-01000000134
108. J-000980
109. Sr-01000000134-3
110. Sr-01000076016-1
111. Sr-01000076016-3
112. Q27268058
113. Maprotiline Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
114. 3-(9,10-ethanoanthracen-9(10h)-yl)-n-methylpropan-1-aminehydrochloride
115. Maprotiline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
116. Maprotiline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
117. Hydron;n-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;chloride
118. Maprotiline Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
119. Methyl(3-{tetracyclo[6.6.2.0(2),?.0?,(1)?]hexadeca-2,4,6,9,11,13-hexaen-1-yl}propyl)amine Hydrochloride
120. Methyl(3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl}propyl)amine Hydrochloride
121. N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;hydrochloride
Molecular Weight | 313.9 g/mol |
---|---|
Molecular Formula | C20H24ClN |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 4 |
Exact Mass | 313.1597275 g/mol |
Monoisotopic Mass | 313.1597275 g/mol |
Topological Polar Surface Area | 12 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 339 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Maprotiline hydrochloride |
Drug Label | Maprotiline hydrochloride, USP is a tetracyclic antidepressant, available as 25 mg, 50 mg and 75 mg tablets for oral administration. Its chemical name is N-methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride, and its structural formula is:C... |
Active Ingredient | Maprotiline hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 75mg; 50mg |
Market Status | Prescription |
Company | Mylan |
2 of 2 | |
---|---|
Drug Name | Maprotiline hydrochloride |
Drug Label | Maprotiline hydrochloride, USP is a tetracyclic antidepressant, available as 25 mg, 50 mg and 75 mg tablets for oral administration. Its chemical name is N-methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride, and its structural formula is:C... |
Active Ingredient | Maprotiline hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg; 75mg; 50mg |
Market Status | Prescription |
Company | Mylan |
Adrenergic Uptake Inhibitors
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?